OmniAb, Inc.
Get $10 bonus on your first $100 deposit for OABI
Get $10 bonus on your first $100 deposit for OABI
OmniAb, Inc. (OABI) Stock Competitors & Peer Comparison
See (OABI) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OABI | $1.48 | -4.52% | 168.4M | -2.60 | -$0.57 | N/A |
| VRTX | $436.59 | -0.59% | 111.1B | 28.48 | $15.33 | N/A |
| REGN | $747.36 | -0.27% | 77.7B | 17.91 | $41.73 | +0.24% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $805.38 | -3.48% | 49.9B | 41.10 | $19.61 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $308.43 | -0.81% | 40.9B | 131.78 | $2.34 | N/A |
| INSM | $140.98 | -1.29% | 30.4B | -21.93 | -$6.43 | N/A |
| RVMD | $148.90 | +1.83% | 29.5B | -24.98 | -$5.96 | N/A |
| BNTX | $111.60 | +6.09% | 28B | -20.11 | -$5.55 | N/A |
Stock Comparison
OABI vs VRTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, VRTX has a market cap of 111.1B. Regarding current trading prices, OABI is priced at $1.48, while VRTX trades at $436.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas VRTX's P/E ratio is 28.48. In terms of profitability, OABI's ROE is -0.24%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, OABI is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check VRTX's competition here
OABI vs REGN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, REGN has a market cap of 77.7B. Regarding current trading prices, OABI is priced at $1.48, while REGN trades at $747.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas REGN's P/E ratio is 17.91. In terms of profitability, OABI's ROE is -0.24%, compared to REGN's ROE of +0.15%. Regarding short-term risk, OABI is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check REGN's competition here
OABI vs VRNA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, OABI is priced at $1.48, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas VRNA's P/E ratio is -102.80. In terms of profitability, OABI's ROE is -0.24%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, OABI is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check VRNA's competition here
OABI vs ARGX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ARGX has a market cap of 49.9B. Regarding current trading prices, OABI is priced at $1.48, while ARGX trades at $805.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ARGX's P/E ratio is 41.10. In terms of profitability, OABI's ROE is -0.24%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, OABI is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ARGX's competition here
OABI vs SGEN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, OABI is priced at $1.48, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas SGEN's P/E ratio is -57.19. In terms of profitability, OABI's ROE is -0.24%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, OABI is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check SGEN's competition here
OABI vs ALNY Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ALNY has a market cap of 40.9B. Regarding current trading prices, OABI is priced at $1.48, while ALNY trades at $308.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ALNY's P/E ratio is 131.78. In terms of profitability, OABI's ROE is -0.24%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, OABI is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ALNY's competition here
OABI vs INSM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, INSM has a market cap of 30.4B. Regarding current trading prices, OABI is priced at $1.48, while INSM trades at $140.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas INSM's P/E ratio is -21.93. In terms of profitability, OABI's ROE is -0.24%, compared to INSM's ROE of -1.68%. Regarding short-term risk, OABI is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check INSM's competition here
OABI vs RVMD Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RVMD has a market cap of 29.5B. Regarding current trading prices, OABI is priced at $1.48, while RVMD trades at $148.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RVMD's P/E ratio is -24.98. In terms of profitability, OABI's ROE is -0.24%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, OABI is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RVMD's competition here
OABI vs BNTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BNTX has a market cap of 28B. Regarding current trading prices, OABI is priced at $1.48, while BNTX trades at $111.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BNTX's P/E ratio is -20.11. In terms of profitability, OABI's ROE is -0.24%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, OABI is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BNTX's competition here
OABI vs UTHR Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, UTHR has a market cap of 25.1B. Regarding current trading prices, OABI is priced at $1.48, while UTHR trades at $573.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas UTHR's P/E ratio is 20.57. In terms of profitability, OABI's ROE is -0.24%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, OABI is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check UTHR's competition here
OABI vs MRNA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MRNA has a market cap of 21.4B. Regarding current trading prices, OABI is priced at $1.48, while MRNA trades at $54.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MRNA's P/E ratio is -7.47. In terms of profitability, OABI's ROE is -0.24%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, OABI is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MRNA's competition here
OABI vs RPRX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RPRX has a market cap of 21.2B. Regarding current trading prices, OABI is priced at $1.48, while RPRX trades at $49.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RPRX's P/E ratio is 27.80. In terms of profitability, OABI's ROE is -0.24%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, OABI is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RPRX's competition here
OABI vs ROIV Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ROIV has a market cap of 21B. Regarding current trading prices, OABI is priced at $1.48, while ROIV trades at $29.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ROIV's P/E ratio is -25.03. In terms of profitability, OABI's ROE is -0.24%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, OABI is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ROIV's competition here
OABI vs SMMT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, SMMT has a market cap of 20.5B. Regarding current trading prices, OABI is priced at $1.48, while SMMT trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas SMMT's P/E ratio is -18.32. In terms of profitability, OABI's ROE is -0.24%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, OABI is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for OABI.Check SMMT's competition here
OABI vs BGNE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, OABI is priced at $1.48, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BGNE's P/E ratio is -22.55. In terms of profitability, OABI's ROE is -0.24%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, OABI is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BGNE's competition here
OABI vs INCY Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, INCY has a market cap of 19.1B. Regarding current trading prices, OABI is priced at $1.48, while INCY trades at $96.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas INCY's P/E ratio is 15.01. In terms of profitability, OABI's ROE is -0.24%, compared to INCY's ROE of +0.29%. Regarding short-term risk, OABI is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check INCY's competition here
OABI vs DNA-WT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, OABI is priced at $1.48, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, OABI's ROE is -0.24%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, OABI is more volatile compared to DNA-WT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check DNA-WT's competition here
OABI vs GMAB Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, GMAB has a market cap of 16.7B. Regarding current trading prices, OABI is priced at $1.48, while GMAB trades at $27.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas GMAB's P/E ratio is 17.57. In terms of profitability, OABI's ROE is -0.24%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, OABI is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check GMAB's competition here
OABI vs BBIO Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BBIO has a market cap of 14.8B. Regarding current trading prices, OABI is priced at $1.48, while BBIO trades at $76.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BBIO's P/E ratio is -20.15. In terms of profitability, OABI's ROE is -0.24%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, OABI is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BBIO's competition here
OABI vs ASND Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ASND has a market cap of 14.8B. Regarding current trading prices, OABI is priced at $1.48, while ASND trades at $240.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ASND's P/E ratio is -54.00. In terms of profitability, OABI's ROE is -0.24%, compared to ASND's ROE of +1.28%. Regarding short-term risk, OABI is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ASND's competition here
OABI vs KRTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, OABI is priced at $1.48, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas KRTX's P/E ratio is -28.09. In terms of profitability, OABI's ROE is -0.24%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, OABI is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check KRTX's competition here
OABI vs IONS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, IONS has a market cap of 12.4B. Regarding current trading prices, OABI is priced at $1.48, while IONS trades at $74.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas IONS's P/E ratio is -31.44. In terms of profitability, OABI's ROE is -0.24%, compared to IONS's ROE of -0.69%. Regarding short-term risk, OABI is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check IONS's competition here
OABI vs JAZZ Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, JAZZ has a market cap of 12.2B. Regarding current trading prices, OABI is priced at $1.48, while JAZZ trades at $199.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas JAZZ's P/E ratio is -34.06. In terms of profitability, OABI's ROE is -0.24%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, OABI is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check JAZZ's competition here
OABI vs MDGL Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MDGL has a market cap of 12.1B. Regarding current trading prices, OABI is priced at $1.48, while MDGL trades at $527.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MDGL's P/E ratio is -41.03. In terms of profitability, OABI's ROE is -0.24%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, OABI is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MDGL's competition here
OABI vs EXEL Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, EXEL has a market cap of 11.9B. Regarding current trading prices, OABI is priced at $1.48, while EXEL trades at $45.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas EXEL's P/E ratio is 16.51. In terms of profitability, OABI's ROE is -0.24%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, OABI is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check EXEL's competition here
OABI vs RNAM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, OABI is priced at $1.48, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RNAM's P/E ratio is -17.39. In terms of profitability, OABI's ROE is -0.24%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, OABI is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RNAM's competition here
OABI vs BMRN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BMRN has a market cap of 10.5B. Regarding current trading prices, OABI is priced at $1.48, while BMRN trades at $54.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BMRN's P/E ratio is 30.34. In terms of profitability, OABI's ROE is -0.24%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, OABI is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BMRN's competition here
OABI vs ARWR Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ARWR has a market cap of 9.9B. Regarding current trading prices, OABI is priced at $1.48, while ARWR trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ARWR's P/E ratio is 44.40. In terms of profitability, OABI's ROE is -0.24%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, OABI is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ARWR's competition here
OABI vs RXDX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, OABI is priced at $1.48, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RXDX's P/E ratio is -56.47. In terms of profitability, OABI's ROE is -0.24%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, OABI is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RXDX's competition here
OABI vs AXSM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, AXSM has a market cap of 9.4B. Regarding current trading prices, OABI is priced at $1.48, while AXSM trades at $182.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas AXSM's P/E ratio is -49.58. In terms of profitability, OABI's ROE is -0.24%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, OABI is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check AXSM's competition here
OABI vs TECH Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TECH has a market cap of 9.3B. Regarding current trading prices, OABI is priced at $1.48, while TECH trades at $59.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TECH's P/E ratio is 110.50. In terms of profitability, OABI's ROE is -0.24%, compared to TECH's ROE of +0.04%. Regarding short-term risk, OABI is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check TECH's competition here
OABI vs IMGN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, OABI is priced at $1.48, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas IMGN's P/E ratio is -111.55. In terms of profitability, OABI's ROE is -0.24%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, OABI is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check IMGN's competition here
OABI vs PCVX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, PCVX has a market cap of 8.7B. Regarding current trading prices, OABI is priced at $1.48, while PCVX trades at $60.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas PCVX's P/E ratio is -10.75. In terms of profitability, OABI's ROE is -0.24%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, OABI is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check PCVX's competition here
OABI vs BPMC Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, OABI is priced at $1.48, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BPMC's P/E ratio is -51.58. In terms of profitability, OABI's ROE is -0.24%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, OABI is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BPMC's competition here
OABI vs IBRX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, IBRX has a market cap of 8.3B. Regarding current trading prices, OABI is priced at $1.48, while IBRX trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas IBRX's P/E ratio is -21.32. In terms of profitability, OABI's ROE is -0.24%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, OABI is more volatile compared to IBRX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check IBRX's competition here
OABI vs CERE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, OABI is priced at $1.48, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CERE's P/E ratio is -16.47. In terms of profitability, OABI's ROE is -0.24%, compared to CERE's ROE of -0.72%. Regarding short-term risk, OABI is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CERE's competition here
OABI vs HALO Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, HALO has a market cap of 8.1B. Regarding current trading prices, OABI is priced at $1.48, while HALO trades at $68.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas HALO's P/E ratio is 26.72. In terms of profitability, OABI's ROE is -0.24%, compared to HALO's ROE of +0.93%. Regarding short-term risk, OABI is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check HALO's competition here
OABI vs CYTK Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CYTK has a market cap of 8.1B. Regarding current trading prices, OABI is priced at $1.48, while CYTK trades at $65.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CYTK's P/E ratio is -10.06. In terms of profitability, OABI's ROE is -0.24%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, OABI is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CYTK's competition here
OABI vs KRYS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, KRYS has a market cap of 8B. Regarding current trading prices, OABI is priced at $1.48, while KRYS trades at $272.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas KRYS's P/E ratio is 39.92. In terms of profitability, OABI's ROE is -0.24%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, OABI is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check KRYS's competition here
OABI vs NUVL Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, NUVL has a market cap of 7.8B. Regarding current trading prices, OABI is priced at $1.48, while NUVL trades at $107.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas NUVL's P/E ratio is -18.31. In terms of profitability, OABI's ROE is -0.24%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, OABI is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check NUVL's competition here
OABI vs MTSR Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, OABI is priced at $1.48, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MTSR's P/E ratio is -23.58. In terms of profitability, OABI's ROE is -0.24%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, OABI is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MTSR's competition here
OABI vs ABVX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ABVX has a market cap of 7.3B. Regarding current trading prices, OABI is priced at $1.48, while ABVX trades at $111.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ABVX's P/E ratio is -19.55. In terms of profitability, OABI's ROE is -0.24%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, OABI is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ABVX's competition here
OABI vs PRAX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, PRAX has a market cap of 7.2B. Regarding current trading prices, OABI is priced at $1.48, while PRAX trades at $340.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas PRAX's P/E ratio is -25.28. In terms of profitability, OABI's ROE is -0.24%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, OABI is more volatile compared to PRAX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check PRAX's competition here
OABI vs KYMR Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, KYMR has a market cap of 7.2B. Regarding current trading prices, OABI is priced at $1.48, while KYMR trades at $88.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas KYMR's P/E ratio is -23.87. In terms of profitability, OABI's ROE is -0.24%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, OABI is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check KYMR's competition here
OABI vs ERAS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ERAS has a market cap of 7B. Regarding current trading prices, OABI is priced at $1.48, while ERAS trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ERAS's P/E ratio is -50.93. In terms of profitability, OABI's ROE is -0.24%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, OABI is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for OABI.Check ERAS's competition here
OABI vs MRUS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, OABI is priced at $1.48, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MRUS's P/E ratio is -17.05. In terms of profitability, OABI's ROE is -0.24%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, OABI is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MRUS's competition here
OABI vs PTGX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, PTGX has a market cap of 6.8B. Regarding current trading prices, OABI is priced at $1.48, while PTGX trades at $105.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas PTGX's P/E ratio is -51.65. In terms of profitability, OABI's ROE is -0.24%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, OABI is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check PTGX's competition here
OABI vs ACLX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, OABI is priced at $1.48, while ACLX trades at $114.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ACLX's P/E ratio is -28.25. In terms of profitability, OABI's ROE is -0.24%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, OABI is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ACLX's competition here
OABI vs BLTE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BLTE has a market cap of 6.6B. Regarding current trading prices, OABI is priced at $1.48, while BLTE trades at $165.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BLTE's P/E ratio is -71.34. In terms of profitability, OABI's ROE is -0.24%, compared to BLTE's ROE of -0.23%. Regarding short-term risk, OABI is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BLTE's competition here
OABI vs RETA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, OABI is priced at $1.48, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RETA's P/E ratio is -66.29. In terms of profitability, OABI's ROE is -0.24%, compared to RETA's ROE of +0.47%. Regarding short-term risk, OABI is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RETA's competition here
OABI vs CELC Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CELC has a market cap of 6.1B. Regarding current trading prices, OABI is priced at $1.48, while CELC trades at $126.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CELC's P/E ratio is -33.21. In terms of profitability, OABI's ROE is -0.24%, compared to CELC's ROE of -2.03%. Regarding short-term risk, OABI is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CELC's competition here
OABI vs CGON Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CGON has a market cap of 6.1B. Regarding current trading prices, OABI is priced at $1.48, while CGON trades at $71.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CGON's P/E ratio is -34.54. In terms of profitability, OABI's ROE is -0.24%, compared to CGON's ROE of -0.23%. Regarding short-term risk, OABI is more volatile compared to CGON. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CGON's competition here
OABI vs COGT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, COGT has a market cap of 6B. Regarding current trading prices, OABI is priced at $1.48, while COGT trades at $36.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas COGT's P/E ratio is -17.00. In terms of profitability, OABI's ROE is -0.24%, compared to COGT's ROE of -1.00%. Regarding short-term risk, OABI is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check COGT's competition here
OABI vs CNTA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CNTA has a market cap of 5.9B. Regarding current trading prices, OABI is priced at $1.48, while CNTA trades at $39.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CNTA's P/E ratio is -27.05. In terms of profitability, OABI's ROE is -0.24%, compared to CNTA's ROE of -0.51%. Regarding short-term risk, OABI is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CNTA's competition here
OABI vs CAI Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CAI has a market cap of 5.9B. Regarding current trading prices, OABI is priced at $1.48, while CAI trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CAI's P/E ratio is -6.47. In terms of profitability, OABI's ROE is -0.24%, compared to CAI's ROE of +0.25%. Regarding short-term risk, OABI is more volatile compared to CAI. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CAI's competition here
OABI vs PTCT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, PTCT has a market cap of 5.8B. Regarding current trading prices, OABI is priced at $1.48, while PTCT trades at $70.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas PTCT's P/E ratio is 8.23. In terms of profitability, OABI's ROE is -0.24%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, OABI is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check PTCT's competition here
OABI vs RYTM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RYTM has a market cap of 5.8B. Regarding current trading prices, OABI is priced at $1.48, while RYTM trades at $84.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RYTM's P/E ratio is -27.31. In terms of profitability, OABI's ROE is -0.24%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, OABI is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RYTM's competition here
OABI vs TGTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TGTX has a market cap of 5.8B. Regarding current trading prices, OABI is priced at $1.48, while TGTX trades at $36.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TGTX's P/E ratio is 13.10. In terms of profitability, OABI's ROE is -0.24%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, OABI is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check TGTX's competition here
OABI vs IMVT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, IMVT has a market cap of 5.8B. Regarding current trading prices, OABI is priced at $1.48, while IMVT trades at $28.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas IMVT's P/E ratio is -10.60. In terms of profitability, OABI's ROE is -0.24%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, OABI is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check IMVT's competition here
OABI vs CDTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, OABI is priced at $1.48, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CDTX's P/E ratio is -19.77. In terms of profitability, OABI's ROE is -0.24%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, OABI is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CDTX's competition here
OABI vs ALKS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ALKS has a market cap of 5.6B. Regarding current trading prices, OABI is priced at $1.48, while ALKS trades at $33.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ALKS's P/E ratio is 23.43. In terms of profitability, OABI's ROE is -0.24%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, OABI is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ALKS's competition here
OABI vs SRRK Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, SRRK has a market cap of 5.5B. Regarding current trading prices, OABI is priced at $1.48, while SRRK trades at $48.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas SRRK's P/E ratio is -14.62. In terms of profitability, OABI's ROE is -0.24%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, OABI is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check SRRK's competition here
OABI vs ABCM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, OABI is priced at $1.48, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, OABI's ROE is -0.24%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, OABI is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ABCM's competition here
OABI vs ISEE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, OABI is priced at $1.48, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ISEE's P/E ratio is -22.44. In terms of profitability, OABI's ROE is -0.24%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, OABI is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ISEE's competition here
OABI vs CRSP Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CRSP has a market cap of 5.3B. Regarding current trading prices, OABI is priced at $1.48, while CRSP trades at $55.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CRSP's P/E ratio is -8.59. In terms of profitability, OABI's ROE is -0.24%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, OABI is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CRSP's competition here
OABI vs FBIOX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, FBIOX has a market cap of 5.3B. Regarding current trading prices, OABI is priced at $1.48, while FBIOX trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas FBIOX's P/E ratio is N/A. In terms of profitability, OABI's ROE is -0.24%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, OABI is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check FBIOX's competition here
OABI vs APLS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, APLS has a market cap of 5.2B. Regarding current trading prices, OABI is priced at $1.48, while APLS trades at $40.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas APLS's P/E ratio is 227.44. In terms of profitability, OABI's ROE is -0.24%, compared to APLS's ROE of +0.08%. Regarding short-term risk, OABI is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check APLS's competition here
OABI vs APGE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, APGE has a market cap of 5.1B. Regarding current trading prices, OABI is priced at $1.48, while APGE trades at $90.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas APGE's P/E ratio is -21.51. In terms of profitability, OABI's ROE is -0.24%, compared to APGE's ROE of -0.37%. Regarding short-term risk, OABI is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check APGE's competition here
OABI vs CORT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CORT has a market cap of 4.8B. Regarding current trading prices, OABI is priced at $1.48, while CORT trades at $45.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CORT's P/E ratio is 55.00. In terms of profitability, OABI's ROE is -0.24%, compared to CORT's ROE of +0.15%. Regarding short-term risk, OABI is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CORT's competition here
OABI vs TERN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TERN has a market cap of 4.8B. Regarding current trading prices, OABI is priced at $1.48, while TERN trades at $52.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TERN's P/E ratio is -51.32. In terms of profitability, OABI's ROE is -0.24%, compared to TERN's ROE of -0.20%. Regarding short-term risk, OABI is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check TERN's competition here
OABI vs MIRM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MIRM has a market cap of 4.7B. Regarding current trading prices, OABI is priced at $1.48, while MIRM trades at $93.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MIRM's P/E ratio is -198.57. In terms of profitability, OABI's ROE is -0.24%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, OABI is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MIRM's competition here
OABI vs LEGN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, LEGN has a market cap of 4.7B. Regarding current trading prices, OABI is priced at $1.48, while LEGN trades at $25.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas LEGN's P/E ratio is -15.57. In terms of profitability, OABI's ROE is -0.24%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, OABI is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check LEGN's competition here
OABI vs FOLD Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, OABI is priced at $1.48, while FOLD trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas FOLD's P/E ratio is -160.67. In terms of profitability, OABI's ROE is -0.24%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, OABI is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check FOLD's competition here
OABI vs LGND Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, LGND has a market cap of 4.5B. Regarding current trading prices, OABI is priced at $1.48, while LGND trades at $226.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas LGND's P/E ratio is 36.98. In terms of profitability, OABI's ROE is -0.24%, compared to LGND's ROE of +0.14%. Regarding short-term risk, OABI is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check LGND's competition here
OABI vs AKRO Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, OABI is priced at $1.48, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas AKRO's P/E ratio is -14.57. In terms of profitability, OABI's ROE is -0.24%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, OABI is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check AKRO's competition here
OABI vs ALPN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, OABI is priced at $1.48, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ALPN's P/E ratio is -101.52. In terms of profitability, OABI's ROE is -0.24%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, OABI is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ALPN's competition here
OABI vs XENE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, XENE has a market cap of 4.5B. Regarding current trading prices, OABI is priced at $1.48, while XENE trades at $56.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas XENE's P/E ratio is -12.94. In terms of profitability, OABI's ROE is -0.24%, compared to XENE's ROE of -0.56%. Regarding short-term risk, OABI is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check XENE's competition here
OABI vs SYRE Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, SYRE has a market cap of 4.3B. Regarding current trading prices, OABI is priced at $1.48, while SYRE trades at $71.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas SYRE's P/E ratio is -35.99. In terms of profitability, OABI's ROE is -0.24%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, OABI is more volatile compared to SYRE. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check SYRE's competition here
OABI vs OPT Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, OABI is priced at $1.48, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas OPT's P/E ratio is -1.52. In terms of profitability, OABI's ROE is -0.24%, compared to OPT's ROE of +0.88%. Regarding short-term risk, OABI is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check OPT's competition here
OABI vs MRTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, OABI is priced at $1.48, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas MRTX's P/E ratio is -4.82. In terms of profitability, OABI's ROE is -0.24%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, OABI is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check MRTX's competition here
OABI vs CRNX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CRNX has a market cap of 4.1B. Regarding current trading prices, OABI is priced at $1.48, while CRNX trades at $38.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CRNX's P/E ratio is -7.86. In terms of profitability, OABI's ROE is -0.24%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, OABI is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CRNX's competition here
OABI vs VKTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, VKTX has a market cap of 3.9B. Regarding current trading prices, OABI is priced at $1.48, while VKTX trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas VKTX's P/E ratio is -10.60. In terms of profitability, OABI's ROE is -0.24%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, OABI is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check VKTX's competition here
OABI vs RYZB Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, OABI is priced at $1.48, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas RYZB's P/E ratio is -57.86. In terms of profitability, OABI's ROE is -0.24%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, OABI is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check RYZB's competition here
OABI vs NAMS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, NAMS has a market cap of 3.7B. Regarding current trading prices, OABI is priced at $1.48, while NAMS trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas NAMS's P/E ratio is -18.88. In terms of profitability, OABI's ROE is -0.24%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, OABI is more volatile compared to NAMS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check NAMS's competition here
OABI vs CBAY Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, OABI is priced at $1.48, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CBAY's P/E ratio is -32.81. In terms of profitability, OABI's ROE is -0.24%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, OABI is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CBAY's competition here
OABI vs ACAD Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ACAD has a market cap of 3.7B. Regarding current trading prices, OABI is priced at $1.48, while ACAD trades at $21.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ACAD's P/E ratio is 9.48. In terms of profitability, OABI's ROE is -0.24%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, OABI is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ACAD's competition here
OABI vs TVTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TVTX has a market cap of 3.6B. Regarding current trading prices, OABI is priced at $1.48, while TVTX trades at $38.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TVTX's P/E ratio is -68.04. In terms of profitability, OABI's ROE is -0.24%, compared to TVTX's ROE of -0.79%. Regarding short-term risk, OABI is more volatile compared to TVTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check TVTX's competition here
OABI vs SWTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, OABI is priced at $1.48, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas SWTX's P/E ratio is -13.78. In terms of profitability, OABI's ROE is -0.24%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, OABI is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check SWTX's competition here
OABI vs EWTX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, EWTX has a market cap of 3.5B. Regarding current trading prices, OABI is priced at $1.48, while EWTX trades at $32.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas EWTX's P/E ratio is -19.91. In terms of profitability, OABI's ROE is -0.24%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, OABI is more volatile compared to EWTX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check EWTX's competition here
OABI vs TLX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TLX has a market cap of 3.5B. Regarding current trading prices, OABI is priced at $1.48, while TLX trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TLX's P/E ratio is -511.50. In terms of profitability, OABI's ROE is -0.24%, compared to TLX's ROE of -0.02%. Regarding short-term risk, OABI is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check TLX's competition here
OABI vs DNTH Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, DNTH has a market cap of 3.5B. Regarding current trading prices, OABI is priced at $1.48, while DNTH trades at $90.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas DNTH's P/E ratio is -21.47. In terms of profitability, OABI's ROE is -0.24%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, OABI is more volatile compared to DNTH. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check DNTH's competition here
OABI vs TNGX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, TNGX has a market cap of 3.2B. Regarding current trading prices, OABI is priced at $1.48, while TNGX trades at $27.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas TNGX's P/E ratio is -31.92. In terms of profitability, OABI's ROE is -0.24%, compared to TNGX's ROE of -0.50%. Regarding short-term risk, OABI is less volatile compared to TNGX. This indicates potentially lower risk in terms of short-term price fluctuations for OABI.Check TNGX's competition here
OABI vs DNLI Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, DNLI has a market cap of 3.2B. Regarding current trading prices, OABI is priced at $1.48, while DNLI trades at $20.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas DNLI's P/E ratio is -6.78. In terms of profitability, OABI's ROE is -0.24%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, OABI is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check DNLI's competition here
OABI vs LQDA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, LQDA has a market cap of 3.2B. Regarding current trading prices, OABI is priced at $1.48, while LQDA trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas LQDA's P/E ratio is -45.29. In terms of profitability, OABI's ROE is -0.24%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, OABI is more volatile compared to LQDA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check LQDA's competition here
OABI vs DYN Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, DYN has a market cap of 3.2B. Regarding current trading prices, OABI is priced at $1.48, while DYN trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas DYN's P/E ratio is -5.54. In terms of profitability, OABI's ROE is -0.24%, compared to DYN's ROE of -0.61%. Regarding short-term risk, OABI is more volatile compared to DYN. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check DYN's competition here
OABI vs CPRX Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, CPRX has a market cap of 3.2B. Regarding current trading prices, OABI is priced at $1.48, while CPRX trades at $25.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas CPRX's P/E ratio is 15.08. In terms of profitability, OABI's ROE is -0.24%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, OABI is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check CPRX's competition here
OABI vs KNSA Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, KNSA has a market cap of 3.1B. Regarding current trading prices, OABI is priced at $1.48, while KNSA trades at $42.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas KNSA's P/E ratio is 56.60. In terms of profitability, OABI's ROE is -0.24%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, OABI is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check KNSA's competition here
OABI vs BEAM Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, BEAM has a market cap of 3.1B. Regarding current trading prices, OABI is priced at $1.48, while BEAM trades at $30.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas BEAM's P/E ratio is -37.86. In terms of profitability, OABI's ROE is -0.24%, compared to BEAM's ROE of -0.07%. Regarding short-term risk, OABI is more volatile compared to BEAM. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check BEAM's competition here
OABI vs ALMS Comparison April 2026
OABI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OABI stands at 168.4M. In comparison, ALMS has a market cap of 3.1B. Regarding current trading prices, OABI is priced at $1.48, while ALMS trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OABI currently has a P/E ratio of -2.60, whereas ALMS's P/E ratio is -8.74. In terms of profitability, OABI's ROE is -0.24%, compared to ALMS's ROE of -0.73%. Regarding short-term risk, OABI is more volatile compared to ALMS. This indicates potentially higher risk in terms of short-term price fluctuations for OABI.Check ALMS's competition here